Allied Market Research
Loading...
0
New
New
2022
Pharmaceutical Glycerin Based Products Market

Pharmaceutical Glycerin Based Products Market by Drug Type (Dermatological, Opthalmic, Cough Remidies, Glycerine Rectal, Angina): Global Opportunity Analysis and Industry Forecast, 2020-2030

A15924
Pages: 196
Mar 2022 | 206 Views
   
Author(s) : Vikita Thakur , Onkar Sumant
Tables: 95
Charts: 53
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Pharmaceutical Glycerin Based Products Market

Request Now !

The global Pharmaceutical Glycerin Based Products Market size was valued at $34.6 billion in 2020 and is projected to reach $61.6 billion by 2030, growing at a CAGR of 5.9% from 2021 to 2030. Pharmaceutical glycerin is an organic compound known as glycerol and glycerin and is majorly used as an excipient in the pharmaceutical industry. Glycerin exhibits various benefits in medical and pharmaceutical preparations, such as improving smoothness, lubrication, and humectant. It is most commonly utilized in the formulation of suppositories, cough syrups, elixirs, and expectorants.

The overall COVID -19 impact remains positive on the pharmaceutical glycerin-based product market owing to its increased usage in hand sanitizers, cough syrups, lozenges, and others. Thus, an increase in the number of COVID-19 infections is expected to lead to increasing the demand for pharmaceutical glycerin-based products globally.

The global pharmaceutical glycerin-based product market is driven by the application of glycerin in the treatment of increased eye pressure conditions, such as glaucoma, and during eye surgery fuels the market growth. Furthermore, an increase in the use of glycerin as a substitute for alcohol in hand sanitizers is anticipated to drive the market. In addition, the increase in adoption of glycerin in the pharmaceutical industry owing to its low cost and various medical benefits, such as moisturizer in skin burns & minor skin irritations, and use in the treatment of constipation are the key factors that drive the growth of the market. Moreover, it also exerts osmotic diuretic properties that support the management of cerebral edema and reduces cerebrospinal pressure and intraocular pressure. However, the adverse effects of pharmaceutical glycerin, such as diarrhea, polyuria, nausea, dry mouth, and others hinder the market growth. Ongoing R&D activities related to pharmaceutical glycerin are anticipated to present new Pharmaceutical Glycerin Based Products Market opportunity.

The Pharmaceutical Glycerin Industry market is segmented on the basis of drug type and region. On the basis of drug type, the market is divided into dermatological, ophthalmic, cough remedies glycerin rectal, and angina. On the basis of region, the pharmaceutical glycerin-based product market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

By Drug Type Segment Review

Pharmaceutical Glycerin Based Products Market
By Drug Type

Your browser does not support the canvas element.

Dermatological segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Based on drug type, into dermatological, ophthalmic, cough remedies glycerin rectal and angina. The dermatological segment generated the highest revenue in 2020 and is expected to maintain its dominance during the forecast period. This is attributed to an increase in the prevalence of skin diseases, such as acne, atopic dermatitis, skin cancer, and rosacea, and a rise in demand for topical dermatological products, which are the key factors driving the Pharmaceutical Glycerin Based Products Market growth. However, the glycerin rectal segment is expected to register the highest growth rate during the forecast period.

By Region Segment Review

Pharmaceutical Glycerin Based Products Market
By Region

2030
Asia-pacific 
North America
Europe
Lamea

Asia-Pacific segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Region-wise, the Pharmaceutical Glycerin Based Products Market analysis is done across North America, Europe, Asia-Pacific, and LAMEA. Asia-Pacific accounted for the largest Pharmaceutical Glycerin Based Products Market share in 2020. The growth can be attributed to the rapidly increasing consumption of pharmaceutical glycerin-based products in countries, such as China, India, and South Korea.

The key players operating in the global pharmaceutical glycerin-based product market include Johnston & Johnson, Abbott, AbbVie Inc. Bausch Health Companies Inc, Takeda Pharmaceutical Companies, The Dow Chemical Company, Dupont, Emery Oleochemicals, Croda International Plc, and Lonza.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pharmaceutical glycerin-based products market analysis from 2020 to 2030 to identify the prevailing pharmaceutical glycerin-based products market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the pharmaceutical glycerin-based products market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global pharmaceutical glycerin based products market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

  • By Drug Type
    • Dermatological
    • Opthalmic
    • Cough Remidies
    • Glycerine Rectal
    • Angina
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • Australia
      • India
      • South Korea
      • Rest Of Asia Pacific
    • LAMEA
      • Brazil
      • South Africa,
      • Saudi Arabia
      • Rest of LAMEA


Key Market Players

  • Johnson and Johnson
  • Abbott Laboratories
  • AbbVie Inc
  • Bausch Health Companies Inc.
  • Takeda Pharmaceutical Company
  • Takeda Pharmaceutical Company Ltd
  • The Dow Chemical Company
  • dupoint
  • Emery Oleochemicals
  • Croda International plc
  • Capsugel
 
  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Top player positioning

    • 3.5.Market dynamics

      • 3.5.1.Drivers

      • 3.5.2.Restraints

      • 3.5.3.Opportunities

    • 3.6.COVID-19 Impact Analysis on the market

  • CHAPTER 4: PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY DRUG TYPE

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2 Dermatological

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market analysis by country

    • 4.3 Opthalmic

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market analysis by country

    • 4.4 Cough Remidies

      • 4.4.1 Key market trends, growth factors and opportunities

      • 4.4.2 Market size and forecast, by region

      • 4.4.3 Market analysis by country

    • 4.5 Glycerine Rectal

      • 4.5.1 Key market trends, growth factors and opportunities

      • 4.5.2 Market size and forecast, by region

      • 4.5.3 Market analysis by country

    • 4.6 Angina

      • 4.6.1 Key market trends, growth factors and opportunities

      • 4.6.2 Market size and forecast, by region

      • 4.6.3 Market analysis by country

  • CHAPTER 5: PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY REGION

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2 North America

      • 5.2.1 Key trends and opportunities

      • 5.2.2 North America Market size and forecast, by Drug Type

      • 5.2.3 North America Market size and forecast, by country

        • 5.2.3.1 U.S.
          • 5.2.3.1.1 Market size and forecast, by Drug Type
        • 5.2.3.2 Canada
          • 5.2.3.2.1 Market size and forecast, by Drug Type
        • 5.2.3.3 Mexico
          • 5.2.3.3.1 Market size and forecast, by Drug Type
    • 5.3 Europe

      • 5.3.1 Key trends and opportunities

      • 5.3.2 Europe Market size and forecast, by Drug Type

      • 5.3.3 Europe Market size and forecast, by country

        • 5.3.3.1 Germany
          • 5.3.3.1.1 Market size and forecast, by Drug Type
        • 5.3.3.2 France
          • 5.3.3.2.1 Market size and forecast, by Drug Type
        • 5.3.3.3 U.K.
          • 5.3.3.3.1 Market size and forecast, by Drug Type
        • 5.3.3.4 Italy
          • 5.3.3.4.1 Market size and forecast, by Drug Type
        • 5.3.3.5 Spain
          • 5.3.3.5.1 Market size and forecast, by Drug Type
        • 5.3.3.6 Rest of Europe
          • 5.3.3.6.1 Market size and forecast, by Drug Type
    • 5.4 Asia-Pacific

      • 5.4.1 Key trends and opportunities

      • 5.4.2 Asia-Pacific Market size and forecast, by Drug Type

      • 5.4.3 Asia-Pacific Market size and forecast, by country

        • 5.4.3.1 Japan
          • 5.4.3.1.1 Market size and forecast, by Drug Type
        • 5.4.3.2 China
          • 5.4.3.2.1 Market size and forecast, by Drug Type
        • 5.4.3.3 Australia
          • 5.4.3.3.1 Market size and forecast, by Drug Type
        • 5.4.3.4 India
          • 5.4.3.4.1 Market size and forecast, by Drug Type
        • 5.4.3.5 South Korea
          • 5.4.3.5.1 Market size and forecast, by Drug Type
        • 5.4.3.6 Rest Of Asia Pacific
          • 5.4.3.6.1 Market size and forecast, by Drug Type
    • 5.5 LAMEA

      • 5.5.1 Key trends and opportunities

      • 5.5.2 LAMEA Market size and forecast, by Drug Type

      • 5.5.3 LAMEA Market size and forecast, by country

        • 5.5.3.1 Brazil
          • 5.5.3.1.1 Market size and forecast, by Drug Type
        • 5.5.3.2 South Africa,
          • 5.5.3.2.1 Market size and forecast, by Drug Type
        • 5.5.3.3 Saudi Arabia
          • 5.5.3.3.1 Market size and forecast, by Drug Type
        • 5.5.3.4 Rest of LAMEA
          • 5.5.3.4.1 Market size and forecast, by Drug Type
  • CHAPTER 6: COMPANY LANDSCAPE

    • 6.1. Introduction

    • 6.2. Top winning strategies

    • 6.3. Product Mapping of Top 10 Player

    • 6.4. Competitive Dashboard

    • 6.5. Competitive Heatmap

    • 6.6. Key developments

  • CHAPTER 7: COMPANY PROFILES

    • 7.1 Johnson and Johnson

      • 7.1.1 Company overview

      • 7.1.2 Company snapshot

      • 7.1.3 Operating business segments

      • 7.1.4 Product portfolio

      • 7.1.5 Business performance

      • 7.1.6 Key strategic moves and developments

    • 7.2 Abbott Laboratories

      • 7.2.1 Company overview

      • 7.2.2 Company snapshot

      • 7.2.3 Operating business segments

      • 7.2.4 Product portfolio

      • 7.2.5 Business performance

      • 7.2.6 Key strategic moves and developments

    • 7.3 AbbVie Inc

      • 7.3.1 Company overview

      • 7.3.2 Company snapshot

      • 7.3.3 Operating business segments

      • 7.3.4 Product portfolio

      • 7.3.5 Business performance

      • 7.3.6 Key strategic moves and developments

    • 7.4 Bausch Health Companies Inc.

      • 7.4.1 Company overview

      • 7.4.2 Company snapshot

      • 7.4.3 Operating business segments

      • 7.4.4 Product portfolio

      • 7.4.5 Business performance

      • 7.4.6 Key strategic moves and developments

    • 7.5 Takeda Pharmaceutical Company

      • 7.5.1 Company overview

      • 7.5.2 Company snapshot

      • 7.5.3 Operating business segments

      • 7.5.4 Product portfolio

      • 7.5.5 Business performance

      • 7.5.6 Key strategic moves and developments

    • 7.6 Takeda Pharmaceutical Company Ltd

      • 7.6.1 Company overview

      • 7.6.2 Company snapshot

      • 7.6.3 Operating business segments

      • 7.6.4 Product portfolio

      • 7.6.5 Business performance

      • 7.6.6 Key strategic moves and developments

    • 7.7 The Dow Chemical Company

      • 7.7.1 Company overview

      • 7.7.2 Company snapshot

      • 7.7.3 Operating business segments

      • 7.7.4 Product portfolio

      • 7.7.5 Business performance

      • 7.7.6 Key strategic moves and developments

    • 7.8 dupoint

      • 7.8.1 Company overview

      • 7.8.2 Company snapshot

      • 7.8.3 Operating business segments

      • 7.8.4 Product portfolio

      • 7.8.5 Business performance

      • 7.8.6 Key strategic moves and developments

    • 7.9 Emery Oleochemicals

      • 7.9.1 Company overview

      • 7.9.2 Company snapshot

      • 7.9.3 Operating business segments

      • 7.9.4 Product portfolio

      • 7.9.5 Business performance

      • 7.9.6 Key strategic moves and developments

    • 7.10 Croda International plc

      • 7.10.1 Company overview

      • 7.10.2 Company snapshot

      • 7.10.3 Operating business segments

      • 7.10.4 Product portfolio

      • 7.10.5 Business performance

      • 7.10.6 Key strategic moves and developments

    • 7.11 Capsugel

      • 7.11.1 Company overview

      • 7.11.2 Company snapshot

      • 7.11.3 Operating business segments

      • 7.11.4 Product portfolio

      • 7.11.5 Business performance

      • 7.11.6 Key strategic moves and developments

    Note: Details on financial performance and strategic moves and developments may not be captured for unlisted companies.

  • LIST OF TABLES

  • TABLE 1. GLOBAL PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY DRUG TYPE, 2020-2030,($MILLION)
    TABLE 2. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET REVENUE, FOR DERMATOLOGICAL, BY REGION , 2020-2030,($MILLION)
    TABLE 3. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET DERMATOLOGICAL BY COUNTRY, 2020-2030,($MILLION)
    TABLE 4. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET REVENUE, FOR OPTHALMIC, BY REGION , 2020-2030,($MILLION)
    TABLE 5. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET OPTHALMIC BY COUNTRY, 2020-2030,($MILLION)
    TABLE 6. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET REVENUE, FOR COUGH REMIDIES, BY REGION , 2020-2030,($MILLION)
    TABLE 7. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET COUGH REMIDIES BY COUNTRY, 2020-2030,($MILLION)
    TABLE 8. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET REVENUE, FOR GLYCERINE RECTAL, BY REGION , 2020-2030,($MILLION)
    TABLE 9. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET GLYCERINE RECTAL BY COUNTRY, 2020-2030,($MILLION)
    TABLE 10. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET REVENUE, FOR ANGINA, BY REGION , 2020-2030,($MILLION)
    TABLE 11. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET ANGINA BY COUNTRY, 2020-2030,($MILLION)
    TABLE 12. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY REGION, 2020-2030,($MILLION)
    TABLE 13. NORTH AMERICA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY DRUG TYPE, 2020-2030,($MILLION)
    TABLE 14. NORTH AMERICA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY COUNTRY, 2020-2030,($MILLION)
    TABLE 15. U.S. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
    TABLE 16. CANADA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
    TABLE 17. MEXICO PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
    TABLE 18. EUROPE PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY DRUG TYPE, 2020-2030,($MILLION)
    TABLE 19. EUROPE PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY COUNTRY, 2020-2030,($MILLION)
    TABLE 20. GERMANY PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
    TABLE 21. FRANCE PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
    TABLE 22. U.K. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
    TABLE 23. ITALY PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
    TABLE 24. SPAIN PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
    TABLE 25. REST OF EUROPE PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
    TABLE 26. ASIA-PACIFIC PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY DRUG TYPE, 2020-2030,($MILLION)
    TABLE 27. ASIA-PACIFIC PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY COUNTRY, 2020-2030,($MILLION)
    TABLE 28. JAPAN PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
    TABLE 29. CHINA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
    TABLE 30. AUSTRALIA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
    TABLE 31. INDIA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
    TABLE 32. SOUTH KOREA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
    TABLE 33. REST OF ASIA PACIFIC PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
    TABLE 34. LAMEA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY DRUG TYPE, 2020-2030,($MILLION)
    TABLE 35. LAMEA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY COUNTRY, 2020-2030,($MILLION)
    TABLE 36. BRAZIL PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
    TABLE 37. SOUTH AFRICA, PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
    TABLE 38. SAUDI ARABIA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
    TABLE 39. REST OF LAMEA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
    TABLE 40.JOHNSON AND JOHNSON: COMPANY SNAPSHOT
    TABLE 41.JOHNSON AND JOHNSON: OPERATING SEGMENTS
    TABLE 42.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
    TABLE 43.JOHNSON AND JOHNSON: NET SALES,
    TABLE 44.JOHNSON AND JOHNSON: KEY STRATERGIES
    TABLE 45.ABBOTT LABORATORIES: COMPANY SNAPSHOT
    TABLE 46.ABBOTT LABORATORIES: OPERATING SEGMENTS
    TABLE 47.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
    TABLE 48.ABBOTT LABORATORIES: NET SALES,
    TABLE 49.ABBOTT LABORATORIES: KEY STRATERGIES
    TABLE 50.ABBVIE INC: COMPANY SNAPSHOT
    TABLE 51.ABBVIE INC: OPERATING SEGMENTS
    TABLE 52.ABBVIE INC: PRODUCT PORTFOLIO
    TABLE 53.ABBVIE INC: NET SALES,
    TABLE 54.ABBVIE INC: KEY STRATERGIES
    TABLE 55.BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT
    TABLE 56.BAUSCH HEALTH COMPANIES INC.: OPERATING SEGMENTS
    TABLE 57.BAUSCH HEALTH COMPANIES INC.: PRODUCT PORTFOLIO
    TABLE 58.BAUSCH HEALTH COMPANIES INC.: NET SALES,
    TABLE 59.BAUSCH HEALTH COMPANIES INC.: KEY STRATERGIES
    TABLE 60.TAKEDA PHARMACEUTICAL COMPANY: COMPANY SNAPSHOT
    TABLE 61.TAKEDA PHARMACEUTICAL COMPANY: OPERATING SEGMENTS
    TABLE 62.TAKEDA PHARMACEUTICAL COMPANY: PRODUCT PORTFOLIO
    TABLE 63.TAKEDA PHARMACEUTICAL COMPANY: NET SALES,
    TABLE 64.TAKEDA PHARMACEUTICAL COMPANY: KEY STRATERGIES
    TABLE 65.TAKEDA PHARMACEUTICAL COMPANY LTD: COMPANY SNAPSHOT
    TABLE 66.TAKEDA PHARMACEUTICAL COMPANY LTD: OPERATING SEGMENTS
    TABLE 67.TAKEDA PHARMACEUTICAL COMPANY LTD: PRODUCT PORTFOLIO
    TABLE 68.TAKEDA PHARMACEUTICAL COMPANY LTD: NET SALES,
    TABLE 69.TAKEDA PHARMACEUTICAL COMPANY LTD: KEY STRATERGIES
    TABLE 70.THE DOW CHEMICAL COMPANY: COMPANY SNAPSHOT
    TABLE 71.THE DOW CHEMICAL COMPANY: OPERATING SEGMENTS
    TABLE 72.THE DOW CHEMICAL COMPANY: PRODUCT PORTFOLIO
    TABLE 73.THE DOW CHEMICAL COMPANY: NET SALES,
    TABLE 74.THE DOW CHEMICAL COMPANY: KEY STRATERGIES
    TABLE 75.DUPOINT: COMPANY SNAPSHOT
    TABLE 76.DUPOINT: OPERATING SEGMENTS
    TABLE 77.DUPOINT: PRODUCT PORTFOLIO
    TABLE 78.DUPOINT: NET SALES,
    TABLE 79.DUPOINT: KEY STRATERGIES
    TABLE 80.EMERY OLEOCHEMICALS: COMPANY SNAPSHOT
    TABLE 81.EMERY OLEOCHEMICALS: OPERATING SEGMENTS
    TABLE 82.EMERY OLEOCHEMICALS: PRODUCT PORTFOLIO
    TABLE 83.EMERY OLEOCHEMICALS: NET SALES,
    TABLE 84.EMERY OLEOCHEMICALS: KEY STRATERGIES
    TABLE 85.CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT
    TABLE 86.CRODA INTERNATIONAL PLC: OPERATING SEGMENTS
    TABLE 87.CRODA INTERNATIONAL PLC: PRODUCT PORTFOLIO
    TABLE 88.CRODA INTERNATIONAL PLC: NET SALES,
    TABLE 89.CRODA INTERNATIONAL PLC: KEY STRATERGIES
    TABLE 90.CAPSUGEL: COMPANY SNAPSHOT
    TABLE 91.CAPSUGEL: OPERATING SEGMENTS
    TABLE 92.CAPSUGEL: PRODUCT PORTFOLIO
    TABLE 93.CAPSUGEL: NET SALES,
    TABLE 94.CAPSUGEL: KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 1.PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET SEGMENTATION
    FIGURE 2.PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030
    FIGURE 3.PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 11.PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,BY DRUG TYPE,2020(%)
    FIGURE 12.COMPARATIVE SHARE ANALYSIS OF DERMATOLOGICAL PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030(%)
    FIGURE 13.COMPARATIVE SHARE ANALYSIS OF OPTHALMIC PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030(%)
    FIGURE 14.COMPARATIVE SHARE ANALYSIS OF COUGH REMIDIES PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030(%)
    FIGURE 15.COMPARATIVE SHARE ANALYSIS OF GLYCERINE RECTAL PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030(%)
    FIGURE 16.COMPARATIVE SHARE ANALYSIS OF ANGINA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030(%)
    FIGURE 17.PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY REGION,2020
    FIGURE 18.U.S. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
    FIGURE 19.CANADA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
    FIGURE 20.MEXICO PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
    FIGURE 21.GERMANY PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
    FIGURE 22.FRANCE PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
    FIGURE 23.U.K. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
    FIGURE 24.ITALY PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
    FIGURE 25.SPAIN PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
    FIGURE 26.REST OF EUROPE PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
    FIGURE 27.JAPAN PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
    FIGURE 28.CHINA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
    FIGURE 29.AUSTRALIA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
    FIGURE 30.INDIA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
    FIGURE 31.SOUTH KOREA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
    FIGURE 32.REST OF ASIA PACIFIC PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
    FIGURE 33.BRAZIL PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
    FIGURE 34.SOUTH AFRICA, PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
    FIGURE 35.SAUDI ARABIA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
    FIGURE 36.REST OF LAMEA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
    FIGURE 37. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 38. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 39. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 40.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 41.COMPETITIVE DASHBOARD
    FIGURE 42.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 43.JOHNSON AND JOHNSON.: NET SALES ,($MILLION)
    FIGURE 44.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
    FIGURE 45.ABBVIE INC.: NET SALES ,($MILLION)
    FIGURE 46.BAUSCH HEALTH COMPANIES INC..: NET SALES ,($MILLION)
    FIGURE 47.TAKEDA PHARMACEUTICAL COMPANY.: NET SALES ,($MILLION)
    FIGURE 48.TAKEDA PHARMACEUTICAL COMPANY LTD.: NET SALES ,($MILLION)
    FIGURE 49.THE DOW CHEMICAL COMPANY.: NET SALES ,($MILLION)
    FIGURE 50.DUPOINT.: NET SALES ,($MILLION)
    FIGURE 51.EMERY OLEOCHEMICALS.: NET SALES ,($MILLION)
    FIGURE 52.CRODA INTERNATIONAL PLC.: NET SALES ,($MILLION)
    FIGURE 53.CAPSUGEL.: NET SALES ,($MILLION)

 
 

The pharmaceutical glycerin-based products market is expected to witness substantial growth owing to an increase in the use of glycerin as a substitute for alcohol in hand sanitizers.

In addition, the increase in adoption of glycerin in the pharmaceutical industry owing to various medical benefits, such as moisturizer in skin burns & minor skin irritations, and cough syrups for dry cough are the key factors anticipated to drive the growth of the market in the upcoming years and in treatment of constipation. Moreover, it also exerts osmotic diuretic properties that support the management of cerebral edema and reduces cerebrospinal pressure and intraocular pressure. However, the adverse effects of pharmaceutical glycerin, such as diarrhea, polyuria, nausea, dry mouth, and others hinder the market growth. Ongoing R&D activities related to pharmaceutical glycerin are anticipated to present new opportunities for the market.

Asia-Pacific accounted for the major share and is likely to dominate the market during the forecast period. The growth can be attributed to the rapidly increasing consumption of the pharmaceutical glycerin-based product in countries such, as China, India, and South Korea.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The top companies to hold the market share in Pharmaceutical Glycerin Based Products are Johnson & Johnson, Abbott, AbbVie Inc. Bausch Health Companies Inc, Takeda Pharmaceutical Companies, The Dow Chemical Company, Dupont, Emery Oleochemicals, Croda International Plc, and Lonza.

A. Asia- Pacific largest regional market for Pharmaceutical Glycerin Based Products

A. The upcoming trends of the Pharmaceutical Glycerin Based Products Market increase in the use of glycerin as a substitute for alcohol in hand sanitizers is anticipated to drive the market. In addition, increase in adoption of glycerin in the pharmaceutical industry owing to its low cost and various medical benefits, such as moisturizer in skin burns & minor skin irritations and use in the treatment of constipation are the key factors that drive the growth of the market.

A. The total market value of the Pharmaceutical Glycerin Based Products Market is $61,603.77 million by 2030.

A. No, there is no value chain analysis provided in the Pharmaceutical Glycerin Based Products Market report

A. The global Pharmaceutical Glycerin Based Products market was valued at $34,592.61 million in 2020

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Pharmaceutical Glycerin Based Products Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2021–2030

Published in Feb 2022

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers